nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—FFAR1—Peptide hormone metabolism—CGA—conduct disorder	0.0756	0.108	CbGpPWpGaD
Icosapent—ACSL3—brain—conduct disorder	0.06	0.2	CbGeAlD
Icosapent—SLC8A1—brain—conduct disorder	0.0498	0.166	CbGeAlD
Icosapent—TRPV1—Ion channel transport—GABRA2—conduct disorder	0.0377	0.0539	CbGpPWpGaD
Icosapent—FABP7—brain—conduct disorder	0.0366	0.122	CbGeAlD
Icosapent—TRPV1—brain—conduct disorder	0.0332	0.111	CbGeAlD
Icosapent—FADS1—brain—conduct disorder	0.0332	0.111	CbGeAlD
Icosapent—ACSL4—brain—conduct disorder	0.0301	0.101	CbGeAlD
Icosapent—PPARD—brain—conduct disorder	0.0289	0.0966	CbGeAlD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0267	0.0381	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0218	0.0311	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CGA—conduct disorder	0.0203	0.029	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0183	0.0261	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0174	0.0249	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0165	0.0236	CbGpPWpGaD
Icosapent—PPARD—NRF2 pathway—SLC6A4—conduct disorder	0.0164	0.0234	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0149	0.0213	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—HTR2A—conduct disorder	0.0147	0.021	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—CGA—conduct disorder	0.0143	0.0204	CbGpPWpGaD
Icosapent—SLC8A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0136	0.0194	CbGpPWpGaD
Icosapent—PPARG—brain—conduct disorder	0.0136	0.0453	CbGeAlD
Icosapent—FADS1—PPARA activates gene expression—EP300—conduct disorder	0.0132	0.0188	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.0132	0.0188	CbGpPWpGaD
Icosapent—TRPV1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0131	0.0188	CbGpPWpGaD
Icosapent—FADS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.0129	0.0184	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CGA—conduct disorder	0.0115	0.0164	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0114	0.0162	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—DRD4—conduct disorder	0.0114	0.0162	CbGpPWpGaD
Icosapent—ACSL3—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.0106	0.0151	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CGA—conduct disorder	0.0104	0.0149	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00974	0.0139	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—CGA—conduct disorder	0.00971	0.0139	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00929	0.0133	CbGpPWpGaD
Icosapent—FADS1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00888	0.0127	CbGpPWpGaD
Icosapent—FADS1—Metabolism—CGA—conduct disorder	0.00814	0.0116	CbGpPWpGaD
Icosapent—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00803	0.0115	CbGpPWpGaD
Icosapent—PTGS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00781	0.0111	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—HTR2A—conduct disorder	0.00742	0.0106	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—CGA—conduct disorder	0.00736	0.0105	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—CGA—conduct disorder	0.00736	0.0105	CbGpPWpGaD
Icosapent—PTGS1—brain—conduct disorder	0.00725	0.0242	CbGeAlD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—EP300—conduct disorder	0.00711	0.0102	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—SLC6A4—conduct disorder	0.00694	0.00991	CbGpPWpGaD
Icosapent—PTGS2—brain—conduct disorder	0.00693	0.0231	CbGeAlD
Icosapent—PPARG—Circadian rythm related genes—DRD4—conduct disorder	0.00653	0.00932	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—DRD4—conduct disorder	0.00642	0.00917	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CGA—conduct disorder	0.00615	0.00878	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—DRD4—conduct disorder	0.00583	0.00833	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—EP300—conduct disorder	0.0055	0.00785	CbGpPWpGaD
Icosapent—PPARG—Signaling events mediated by HDAC Class I—EP300—conduct disorder	0.00525	0.00749	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00507	0.00724	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—POLR3A—conduct disorder	0.00506	0.00723	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—WASF1—conduct disorder	0.00493	0.00704	CbGpPWpGaD
Icosapent—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—conduct disorder	0.00486	0.00694	CbGpPWpGaD
Icosapent—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00451	0.00645	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—COMT—conduct disorder	0.00438	0.00626	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—MAOA—conduct disorder	0.00435	0.00621	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00422	0.00603	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—HTR2A—conduct disorder	0.00419	0.00598	CbGpPWpGaD
Icosapent—PTGS1—Biological oxidations—COMT—conduct disorder	0.00418	0.00596	CbGpPWpGaD
Icosapent—PTGS1—Biological oxidations—MAOA—conduct disorder	0.00415	0.00592	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CGA—conduct disorder	0.00414	0.0059	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00408	0.00583	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HTR2A—conduct disorder	0.00381	0.00543	CbGpPWpGaD
Icosapent—FADS1—Metabolism—COMT—conduct disorder	0.00367	0.00524	CbGpPWpGaD
Icosapent—PPARG—PPARA activates gene expression—EP300—conduct disorder	0.00366	0.00522	CbGpPWpGaD
Icosapent—FADS1—Metabolism—MAOA—conduct disorder	0.00365	0.00521	CbGpPWpGaD
Icosapent—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00358	0.00511	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00355	0.00507	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00354	0.00505	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—DRD4—conduct disorder	0.00345	0.00492	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—COMT—conduct disorder	0.00332	0.00474	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—COMT—conduct disorder	0.00332	0.00474	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—MAOA—conduct disorder	0.0033	0.00471	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—MAOA—conduct disorder	0.0033	0.00471	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—EP300—conduct disorder	0.00324	0.00463	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.0032	0.00457	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00282	0.00403	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—POLR3A—conduct disorder	0.00277	0.00395	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—EP300—conduct disorder	0.00252	0.0036	CbGpPWpGaD
Icosapent—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00246	0.00352	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CGA—conduct disorder	0.00226	0.00322	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—EP300—conduct disorder	0.00226	0.00322	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HTR2A—conduct disorder	0.00225	0.00321	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—EP300—conduct disorder	0.00188	0.00268	CbGpPWpGaD
Icosapent—PPARD—Metabolism—COMT—conduct disorder	0.00187	0.00267	CbGpPWpGaD
Icosapent—PPARD—Metabolism—MAOA—conduct disorder	0.00185	0.00265	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.0018	0.00257	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CGA—conduct disorder	0.00158	0.00226	CbGpPWpGaD
Icosapent—FADS1—Metabolism—EP300—conduct disorder	0.00158	0.00225	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—EP300—conduct disorder	0.00142	0.00203	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—EP300—conduct disorder	0.00142	0.00203	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00131	0.00187	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CGA—conduct disorder	0.00126	0.00179	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EP300—conduct disorder	0.00119	0.0017	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EP300—conduct disorder	0.0011	0.00157	CbGpPWpGaD
Icosapent—PPARG—Metabolism—COMT—conduct disorder	0.00102	0.00146	CbGpPWpGaD
Icosapent—PPARG—Metabolism—MAOA—conduct disorder	0.00101	0.00145	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000982	0.0014	CbGpPWpGaD
Icosapent—PPARD—Metabolism—EP300—conduct disorder	0.000801	0.00114	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—COMT—conduct disorder	0.000714	0.00102	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—MAOA—conduct disorder	0.000709	0.00101	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000688	0.000982	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—COMT—conduct disorder	0.000567	0.000809	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MAOA—conduct disorder	0.000563	0.000804	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000546	0.000779	CbGpPWpGaD
Icosapent—PPARG—Metabolism—EP300—conduct disorder	0.000437	0.000624	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—EP300—conduct disorder	0.000306	0.000437	CbGpPWpGaD
Icosapent—PTGS2—Disease—EP300—conduct disorder	0.00029	0.000414	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—EP300—conduct disorder	0.000243	0.000347	CbGpPWpGaD
